AME Cloud Ventures — 2024 Investments
4 investments dated 2024 · listed companies and verified rows first · show all
Elegant Bio develops DNA synthesis technology and services, offering ENFINIA™ DNA synthesis at scale for biotech and research applications.
BiotechDeep TechSan Carlos, US
Matthew Hill(Executive Officer, Director)in
BoardPeter Zhou(Director)inCain McClary(Director)inJonathan Sheena(Director)in
Co-investorsACVC PartnersAndreessen HorowitzIn-Q-TelKdT VenturesRaptor GroupTriatomic Capital+1 more
Ema builds "Universal AI Employees" — AI agents designed to perform business tasks and automate repetitive work across an organization.
AI & Machine LearningEnterprise SoftwareFuture of WorkSaaS
Surojit Chatterjee(Co-Founder & CEO)inSouvik Sen(Co-Founder & CTO)in
Co-investorsAccelColle Capital PartnersHitachi VenturesS32Section 32Transpose Platform Management+7 more
Overview AI builds AI-powered vision systems that detect manufacturing defects in real-time across production lines, learning and adapting to any product within hours.
Advanced ManufacturingAI & Machine LearningDeep TechIoTRoboticsSan Francisco, US
Austin Appel(Founder)inRussell Nibbelink(Founder)inChristopher Van Dyke(Founder)inXiaoyang Kao(Founder)inDaniel Chen(GTM)Sarah Ham(Future COO)
Co-investorsAlumni VenturesArray Ventures Management LlcBlumberg CapitalCorrelation VenturesGV (Google Ventures)Homebrew+13 more
Voicepanel provides customer research tools to help companies understand their customers faster and more reliably than traditional research methods.
AI & Machine LearningData & InfrastructureDeveloper ToolsEnterprise SoftwareMarketing TechSaaSSan Francisco, US
Asa Schachar(CTO)inJohn Provine(CEO)inDavidinJohn(Co-founder)Asa(Co-founder)
Co-investorsY CombinatorMaiora Rebel VenturesRebel FundLiquid VenturesRomulus CapitalSequoia Capital+1 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.





























